Silynxcom Ltd Dossier
Financial Snapshot
Revenue, profitability, returns, debt, and capital allocation
Revenue $9.1M+19.1% YoYTTM through 30 Jun 2025
Net Income -$2.3MTTM through 30 Jun 2025
Free Cash Flow -$1.1MTTM through 30 Jun 2025
Margins
| Current | |
|---|---|
| Gross Margin | 36.1% |
| EBITDA Margin | -14.6% |
| Operating Margin | -51.6% |
| Net Margin | -25.8% |
Returns
-56.4%ROE
-34.7%ROA
Balance Sheet Health
Debt / Equity0.00x
Current Ratio4.31x
Net Debt-$3Mnet cash position
Cash & Equivalents$3.5M
Quality Metrics
Piotroski F-Score4 / 9
FCF Margin-11.8%
Multi-Year Trend
RevenueFY2024: $9.1M
Diluted EPSFY2024: $-0.45
Dividend
No dividend
Capital Allocation
Capex Intensity1.2%
Segment Performance
| Segment | Revenue | YoY | Outlook |
|---|---|---|---|
| Israel (IDF) | $4.3M | View detailsIsrael remains the primary market with significant ongoing demand. |
Filing Detail Members
This section is available to registered members. Create a free account or sign in to unlock the full breakdown.